Issam Awad to Cerebral Hemorrhage
This is a "connection" page, showing publications Issam Awad has written about Cerebral Hemorrhage.
Connection Strength
12.318
-
In Reply: Intracerebral Hemorrhage Volume Reduction and Timing of Intervention Versus Functional Benefit and Survival in the MISTIE III and STICH Trials. Neurosurgery. 2021 09 15; 89(4):E247-E248.
Score: 0.649
-
Post-Trial Enhanced Deployment and Technical Performance with the MISTIE Procedure per Lessons Learned. J Stroke Cerebrovasc Dis. 2021 Sep; 30(9):105996.
Score: 0.642
-
A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH). Neurosurgery. 2021 02 16; 88(3):686-697.
Score: 0.623
-
In Reply: Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure. Neurosurgery. 2020 04 01; 86(4):E411.
Score: 0.587
-
Surgery for intracerebral haemorrhage - Authors' reply. Lancet. 2019 08 24; 394(10199):e22-e23.
Score: 0.563
-
Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial. Neurosurgery. 2017 Nov 01; 81(5):860-866.
Score: 0.496
-
Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations. Transl Stroke Res. 2018 02; 9(1):34-43.
Score: 0.489
-
Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage. J Magn Reson Imaging. 2018 04; 47(4):1133-1138.
Score: 0.488
-
Spontaneous intracerebral and intraventricular hemorrhage: advances in minimally invasive surgery and thrombolytic evacuation, and lessons learned in recent trials. Neurosurgery. 2014 Feb; 74 Suppl 1:S142-50.
Score: 0.383
-
Thrombolytic evacuation of intracerebral and intraventricular hemorrhage. Curr Cardiol Rep. 2012 Dec; 14(6):754-60.
Score: 0.353
-
Ventricular catheter location and the clearance of intraventricular hemorrhage. Neurosurgery. 2012 May; 70(5):1258-63; discussion 1263-4.
Score: 0.339
-
External ventricular drainage for intraventricular hemorrhage. Curr Neurol Neurosci Rep. 2012 Feb; 12(1):24-33.
Score: 0.333
-
Outcome predictors and spectrum of treatment eligibility with prospective protocolized management of intracerebral hemorrhage. Neurosurgery. 2009 Mar; 64(3):436-45; discussion 445-6.
Score: 0.272
-
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling. Stroke. 2024 01; 55(1):31-39.
Score: 0.190
-
Minimally Invasive Surgery With Thrombolysis for Intracerebral Hemorrhage Evacuation: Bayesian Reanalysis of a Randomized Controlled Trial. Neurology. 2023 10 17; 101(16):e1614-e1622.
Score: 0.186
-
Intraventricular Hemorrhage Expansion in the CLEAR III Trial: A Post Hoc Exploratory Analysis. Stroke. 2022 06; 53(6):1847-1853.
Score: 0.166
-
Association Between Intraventricular Alteplase Use and Parenchymal Hematoma Volume in Patients With Spontaneous Intracerebral Hemorrhage and Intraventricular Hemorrhage. JAMA Netw Open. 2021 12 01; 4(12):e2135773.
Score: 0.165
-
Baseline Characteristics of Patients With Cavernous Angiomas With Symptomatic Hemorrhage in Multisite Trial Readiness Project. Stroke. 2021 12; 52(12):3829-3838.
Score: 0.162
-
Post-Stroke Depression in Patients with Large Spontaneous Intracerebral Hemorrhage. J Stroke Cerebrovasc Dis. 2021 Nov; 30(11):106082.
Score: 0.162
-
CSF and serum inflammatory response and association with outcomes in spontaneous intracerebral hemorrhage with intraventricular extension: an analysis of the CLEAR-III Trial. J Neuroinflammation. 2021 Aug 21; 18(1):179.
Score: 0.161
-
Intracerebral Hemorrhage Volume Reduction and Timing of Intervention Versus Functional Benefit and Survival in the MISTIE III and STICH Trials. Neurosurgery. 2021 04 15; 88(5):961-970.
Score: 0.158
-
Leukocyte dynamics after intracerebral hemorrhage in a living patient reveal rapid adaptations to tissue milieu. JCI Insight. 2021 03 22; 6(6).
Score: 0.157
-
Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhage. Sci Immunol. 2021 02 19; 6(56).
Score: 0.156
-
Temporal Evolution and Outcomes of Non-Traumatic Intracerebral Hemorrhage in Hospitalized Patients. J Stroke Cerebrovasc Dis. 2021 Mar; 30(3):105584.
Score: 0.155
-
A Pooled Analysis of Diffusion-Weighted Imaging Lesions in Patients With Acute Intracerebral Hemorrhage. JAMA Neurol. 2020 11 01; 77(11):1390-1397.
Score: 0.153
-
3D Deep Neural Network Segmentation of Intracerebral Hemorrhage: Development and Validation for Clinical Trials. Neuroinformatics. 2021 07; 19(3):403-415.
Score: 0.152
-
Role of Temporal Sequence in Treating Intracerebral Hemorrhage. Ann Neurol. 2020 08; 88(2):237-238.
Score: 0.149
-
Stereotactic computed tomographic-guided aspiration and thrombolysis of intracerebral hematoma : protocol and preliminary experience. Stroke. 2000 Apr; 31(4):834-40.
Score: 0.147
-
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial. Neurosurgery. 2019 12 01; 85(6):843-853.
Score: 0.143
-
A randomized 500-subject open-label phase 3 clinical trial of minimally invasive surgery plus alteplase in intracerebral hemorrhage evacuation (MISTIE III). Int J Stroke. 2019 07; 14(5):548-554.
Score: 0.137
-
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019 Mar 09; 393(10175):1021-1032.
Score: 0.135
-
Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice. Blood. 2019 01 17; 133(3):193-204.
Score: 0.133
-
Surgery for intracerebral hemorrhage. Neurology. 1998 Sep; 51(3 Suppl 3):S69-73.
Score: 0.131
-
The Incidence of Catheter Tract Hemorrhage and Catheter Placement Accuracy in the CLEAR III Trial. Neurocrit Care. 2018 08; 29(1):23-32.
Score: 0.131
-
CSF inflammatory response after intraventricular hemorrhage. Neurology. 2017 Oct 10; 89(15):1553-1560.
Score: 0.123
-
Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial. Neurology. 2017 Jul 25; 89(4):355-362.
Score: 0.121
-
Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial. Lancet Neurol. 2016 Nov; 15(12):1228-1237.
Score: 0.115
-
Accuracy of the ABC/2 Score for Intracerebral Hemorrhage: Systematic Review and Analysis of MISTIE, CLEAR-IVH, and CLEAR III. Stroke. 2015 Sep; 46(9):2470-6.
Score: 0.106
-
Bleeding and infection with external ventricular drainage: a systematic review in comparison with adjudicated adverse events in the ongoing Clot Lysis Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III (CLEAR-III IHV) trial. Neurosurgery. 2015 Mar; 76(3):291-300; discussion 301.
Score: 0.103
-
Determinants of external ventricular drain placement and associated outcomes in patients with spontaneous intraventricular hemorrhage. Neurocrit Care. 2014 Dec; 21(3):426-34.
Score: 0.101
-
A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III). Int J Stroke. 2014 Jun; 9(4):536-42.
Score: 0.093
-
Hemorrhagic stroke: introduction. Stroke. 2013 Jun; 44(6 Suppl 1):S65-6.
Score: 0.091
-
Surgical trials in intracerebral hemorrhage. Stroke. 2013 Jun; 44(6 Suppl 1):S79-82.
Score: 0.091
-
Comparison of the clinical presentation of symptomatic arteriovenous malformations (angiographically visualized) and occult vascular malformations. Neurosurgery. 1993 May; 32(5):876-8.
Score: 0.091
-
Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema. Stroke. 2013 Mar; 44(3):627-34.
Score: 0.089
-
The Modified Graeb Score: an enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcome. Stroke. 2013 Mar; 44(3):635-41.
Score: 0.089
-
Intensive care management of acute hemorrhagic leukoencephalitis with favorable neurologic outcome. Cleve Clin J Med. 1992 Sep-Oct; 59(5):549-52.
Score: 0.087
-
Drainage efficiency with dual versus single catheters in severe intraventricular hemorrhage. Neurocrit Care. 2012 Jun; 16(3):399-405.
Score: 0.085
-
Occurrence and impact of intracranial pressure elevation during treatment of severe intraventricular hemorrhage. Crit Care Med. 2012 May; 40(5):1601-8.
Score: 0.085
-
Resolution of intraventricular hemorrhage varies by ventricular region and dose of intraventricular thrombolytic: the Clot Lysis: Evaluating Accelerated Resolution of IVH (CLEAR IVH) program. Stroke. 2012 Jun; 43(6):1666-8.
Score: 0.084
-
Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease. Stroke. 2012 Feb; 43(2):571-4.
Score: 0.082
-
Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke. 2011 Nov; 42(11):3009-16.
Score: 0.081
-
Intraventricular hemorrhage secondary to intranidal aneurysm rupture-successful management by arteriovenous malformation embolization followed by intraventricular tissue plasminogen activator: case report. Neurosurgery. 2011 Feb; 68(2):E581-6; discussion E586.
Score: 0.078
-
Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board. Stroke. 2008 Dec; 39(12):3222-30.
Score: 0.066
-
Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial. Acta Neurochir Suppl. 2008; 105:217-20.
Score: 0.063
-
Current updates in perioperative management of intracerebral hemorrhage. Neurol Clin. 2006 Nov; 24(4):745-64.
Score: 0.058
-
Cerebral cavernous malformations and epilepsy. Neurosurg Focus. 2006 Jul 15; 21(1):e7.
Score: 0.057
-
[Etiologic spectrum of intracerebral hemorrhage in young patients]. Neurochirurgie. 2006 Jun; 52(2-3 Pt 1):105-9.
Score: 0.056
-
Antithrombotic Therapy in Cerebral Cavernous Malformations: A Systematic Review, Meta-Analysis, and Network Meta-Analysis. J Am Heart Assoc. 2024 Mar 19; 13(6):e032910.
Score: 0.048
-
Association Between Hematoma Volume and Risk of Subsequent Ischemic Stroke: A MISTIE III and ATACH-2 Analysis. Stroke. 2024 Mar; 55(3):541-547.
Score: 0.048
-
Catheter Tract Hemorrhages and Intracerebral Hemorrhage Outcomes in the Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Trial. Neurosurgery. 2024 02 01; 94(2):334-339.
Score: 0.047
-
One-Year Outcome Trajectories and Factors Associated with Functional Recovery Among Survivors of Intracerebral and Intraventricular Hemorrhage With Initial Severe Disability. JAMA Neurol. 2022 09 01; 79(9):856-868.
Score: 0.043
-
Association of Intraventricular Fibrinolysis With Clinical Outcomes in Intracerebral Hemorrhage: An Individual Participant Data Meta-Analysis. Stroke. 2022 09; 53(9):2876-2886.
Score: 0.042
-
Bayesian deep learning outperforms clinical trial estimators of intracerebral and intraventricular hemorrhage volume. J Neuroimaging. 2022 09; 32(5):968-976.
Score: 0.042
-
Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions. Circ Res. 2022 04 15; 130(8):1204-1229.
Score: 0.042
-
Cerebral Microbleeds and Acute Hematoma Characteristics in the ATACH-2 and MISTIE III Trials. Neurology. 2022 03 08; 98(10):e1013-e1020.
Score: 0.041
-
A quality-of-life instrument for young hemorrhagic stroke patients. Stroke. 2001 Mar; 32(3):687-95.
Score: 0.039
-
Thrombolysis for Evacuation of Intracerebral and Intraventricular Hemorrhage: A Guide to Surgical Protocols With Practical Lessons Learned From the MISTIE and CLEAR Trials. Oper Neurosurg (Hagerstown). 2020 12 15; 20(1):98-108.
Score: 0.039
-
Relationship of White Matter Lesions with Intracerebral Hemorrhage Expansion and Functional Outcome: MISTIE II and CLEAR III. Neurocrit Care. 2020 10; 33(2):516-524.
Score: 0.038
-
Primary intraventricular hemorrhage outcomes in the CLEAR III trial. Int J Stroke. 2020 10; 15(8):872-880.
Score: 0.036
-
Hemorrhagic lesion at the tentorial incisura in a patient with facial nevus. Neurosurgery. 1999 Nov; 45(5):1216-21.
Score: 0.036
-
A comparison of the clinical profile of cavernous malformations with and without associated venous malformations. Neurosurgery. 1999 Jan; 44(1):41-6; discussion 46-7.
Score: 0.034
-
Protocols and critical pathways for stroke care. Clin Neurosurg. 1999; 45:86-100.
Score: 0.034
-
Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth. Circ Res. 2018 06 08; 122(12):1716-1721.
Score: 0.032
-
Intracranial cavernous malformations: lesion behavior and management strategies. Neurosurgery. 1995 Oct; 37(4):591-605.
Score: 0.027
-
Radiosurgery and venous malformations. J Neurosurg. 1994 Jan; 80(1):171-3; author reply 174-5.
Score: 0.024
-
Mixed vascular malformations of the brain: clinical and pathogenetic considerations. Neurosurgery. 1993 Aug; 33(2):179-88; discussion 188.
Score: 0.023
-
Intracranial dural arteriovenous malformations: factors predisposing to an aggressive neurological course. J Neurosurg. 1990 Jun; 72(6):839-50.
Score: 0.019
-
Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. Stroke. 2001 Jun; 32(6):1430-42.
Score: 0.010
-
Advances in the genetics of cerebrovascular disease and stroke. Neurology. 2001 Apr 24; 56(8):997-1008.
Score: 0.010
-
Parenchymal perianeurysmal cystic changes in the brain: report of five cases. Radiology. 2000 Apr; 215(1):229-33.
Score: 0.009
-
Factors predisposing to clinical disability in patients with cavernous malformations of the brain. Neurosurgery. 1993 May; 32(5):730-5; discussion 735-6.
Score: 0.006
-
Natural history of the cavernous angioma. J Neurosurg. 1991 Nov; 75(5):709-14.
Score: 0.005
-
Proton magnetic resonance imaging in ischemic cerebrovascular disease. Ann Neurol. 1986 Oct; 20(4):502-7.
Score: 0.004